Suppr超能文献

累及肾脏的黏液瘤与黏液样脂肪肉瘤

Myxoma versus myxoid liposarcoma involving the kidneys.

作者信息

Findeis Sarah K, Salicru Mauricio N, Agarwal Atin

机构信息

Department of Pathology, Baylor University Medical CenterDallasTexas.

Department of Pathology, Methodist Dallas Medical CenterDallasTexas.

出版信息

Proc (Bayl Univ Med Cent). 2019 Jun 11;32(3):402-404. doi: 10.1080/08998280.2019.1613328. eCollection 2019 Jul.

Abstract

Myxoid lesions of the kidney are rare. We present a case of a 74-year-old man who presented with an 8.5 × 8.0 × 6.0 cm left kidney mass that was grossly confined to the kidney and had a gelatinous cut surface. Histology of the tumor showed bland spindle cells in a myxoid stroma with interspersed thin-walled vessels. The tumor was negative for smooth muscle actin, desmin, CD34 (highlighted vessels), S100, and HMB-45 by immunohistochemistry. There was focal, nonspecific staining of MDM2 and CDK4. The lesion appeared more vascular than would be expected for a classic myxoma and, therefore, fluorescence in situ hybridization was performed for the 12q13 ( or ) rearrangement to rule out myxoid liposarcoma and the result was negative for a rearrangement. This case highlights the difficulty of delineating a primary myxoma of the kidney from a well-differentiated myxoid liposarcoma.

摘要

肾脏黏液样病变较为罕见。我们报告一例74岁男性病例,其左肾有一个大小为8.5×8.0×6.0 cm的肿块,大体上局限于肾脏,切面呈胶冻状。肿瘤组织学显示,在黏液样基质中有温和的梭形细胞,其间散在薄壁血管。免疫组织化学检测显示,肿瘤平滑肌肌动蛋白、结蛋白、CD34(突出显示血管)、S100和HMB-45均为阴性。MDM2和CDK4有局灶性非特异性染色。该病变的血管比典型黏液瘤预期的要多,因此进行了荧光原位杂交检测12q13(或)重排,以排除黏液样脂肪肉瘤,结果重排为阴性。该病例凸显了区分原发性肾脏黏液瘤与高分化黏液样脂肪肉瘤的困难。

相似文献

1
Myxoma versus myxoid liposarcoma involving the kidneys.累及肾脏的黏液瘤与黏液样脂肪肉瘤
Proc (Bayl Univ Med Cent). 2019 Jun 11;32(3):402-404. doi: 10.1080/08998280.2019.1613328. eCollection 2019 Jul.

本文引用的文献

1
Primary Retroperitoneal Myxoid Liposarcomas.原发性腹膜后黏液样脂肪肉瘤
Am J Surg Pathol. 2016 Sep;40(9):1286-90. doi: 10.1097/PAS.0000000000000657.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验